Halozyme HALO
First Signal's file · in 1 issue · All companies
Drug-delivery technology
Every time it made the issue
We cover a company only when it moves enough to matter. Each row is one of those days, what we made of it, and how the stock did over the next 5 and 20 trading days, next to the S&P 500.
| Date | Where | Move | Our read | 5 days later | 20 days later |
|---|---|---|---|---|---|
| Fri, Nov 6, 2026 | Earnings | −15.7% | Revenue rose 39% and it raised EPS guidance, while adding $60 million of Hypercon and Aerocon investment, its release shows. | to come | to come |
Its biggest days of the past ten years
| Best days | Move |
|---|---|
| Thu, Sep 14, 2017 | +21.2% |
| Fri, Aug 7, 2026 | +20.2% |
| Wed, Nov 9, 2016 | +18.2% |
| Worst days | Move |
|---|---|
| Tue, May 13, 2025 | −24.6% |
| Fri, Nov 6, 2026 | −15.7% |
| Fri, Nov 15, 2024 | −15.4% |
How it took its last 8 reports
The stock's move in the first session after each quarterly report. Next report: Tuesday, February 16, 2027.
| Results filed | Next session |
|---|---|
| Thu, Nov 5, 2026 | −15.7% |
| Thu, Aug 6, 2026 | +20.2% |
| Mon, May 11, 2026 | +6.8% |
| Tue, Feb 17, 2026 | −9.0% |
| Mon, Nov 3, 2025 | +2.8% |
| Tue, Aug 5, 2025 | +2.5% |
| Tue, May 6, 2025 | +18.1% |
| Tue, Feb 18, 2025 | −0.2% |
Moves are daily closing prices. Past moves don't predict future ones.
